GlassScriptPhysician profile
Son Giep
NPI 1801839253
$7,099.87
in general payments reported to CMS, 2019-2025
41 companies · $477 in 2025
The $477 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,510 · 2020: $1,892 · 2021: $1,126 · 2022: $555 · 2023: $817 · 2024: $723 · 2025: $477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,017.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,017.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,219.69 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $790.58 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Viiv Healthcare Company | $570.99 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $473.29 | 2019-2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $419.64 | 2019-2023 | |
| Lilly USA, LLC | $359.21 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Abbott Laboratories | $314.91 | 2019-2025 | Freestyle Libre 3, Freestyle Libre 2, Id Now Instrument |
| Amgen INC. | $271.31 | 2019-2025 | Evenity, Prolia, Repatha |
| Amarin Pharma, INC. | $256.19 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $250.28 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $195.84 | 2019-2023 | Xarelto |
| Abbvie INC. | $193.07 | 2019-2024 | |
| Eisai INC. | $192.58 | 2020-2022 | |
| Genentech USA, INC. | $192.42 | 2019-2021 | |
| Exact Sciences Corporation | $189.01 | 2023-2025 | Cologuard Collection Kit |
Show all 38 companies
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Son Giep listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.